BreakingHealthLatin AmericaRecommendationsWorld

Cuba Announces Clinical Trial Of Anti-Alzheimer’s Drug

Cuba will conduct a clinical trial with a drug developed in the island to work toward a more effective treatment for Alzheimer’s patients.

The drug NeuroEpo was developed by scientific institutions in Cuba, and its tests are expected to reduce the signs and side effects of the disease and improve patients’ quality of life.

The Center for Molecular Immunology in Havana will begin to apply the medicine to patients in the early stages of Alzheimer’s disease, according to research specialists cited by Granma.

lzheimer’s disease is the most common neurodegenerative disease in people over 60 years old and the sixth leading cause of death in Cuba, according to Jorge Llibre Guerra, a specialist at the National Institute of Neurology and Neurosurgery.

In the world, there are currently about 300 clinical trials in progress regarding Alzheimer’s disease.

[adrotate group=”10″]

Related Articles

Bir yanıt yazın

Başa dön tuşu
Breaking News